PADAMOLOGY LIBRARY

Published Research

Practical insights on medical monitoring, patient safety, trial execution, and the decisions that shape early oncology development.

Simran Padam 7/1/21 Simran Padam 7/1/21

Phase I/II Trial of Palbociclib, Pembrolizumab, and Letrozole in Patients with Hormone Receptor-Positive Metastatic Breast Cancer

A Phase I/II study evaluating palbociclib, pembrolizumab, and letrozole in hormone receptor-positive metastatic breast cancer.

Simran Padam 3/21/21 Simran Padam 3/21/21

A Phase II study of neratinib in older adults with HER2-amplified or HER2/3-mutated metastatic breast cancer.

Simran Padam 2/1/21 Simran Padam 2/1/21

A Phase II trial evaluating pembrolizumab and enobosarm in androgen receptor-positive metastatic triple-negative breast cancer.

Simran Padam 4/2/20 Simran Padam 4/2/20

Research examining community oncologists’ perceptions of barriers to participation in therapeutic clinical trials.

Simran Padam 7/31/19 Simran Padam 7/31/19

A Phase II study investigating pembrolizumab, letrozole, and palbociclib in patients with metastatic estrogen receptor-positive breast cancer.